
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About


Movano Inc (MOVE)


- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)

(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/20/2025: MOVE (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $300
1 Year Target Price $300
0 | Strong Buy |
1 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -59.53% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() | ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 6.23M USD | Price to earnings Ratio - | 1Y Target Price 300 |
Price to earnings Ratio - | 1Y Target Price 300 | ||
Volume (30-day avg) 1 | Beta 0.85 | 52 Weeks Range 5.10 - 69.67 | Updated Date 10/20/2025 |
52 Weeks Range 5.10 - 69.67 | Updated Date 10/20/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -27.7 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -3165.05% |
Management Effectiveness
Return on Assets (TTM) -97.08% | Return on Equity (TTM) -219.6% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 3361892 | Price to Sales(TTM) 13.25 |
Enterprise Value 3361892 | Price to Sales(TTM) 13.25 | ||
Enterprise Value to Revenue 7.15 | Enterprise Value to EBITDA -1.24 | Shares Outstanding 834908 | Shares Floating 678238 |
Shares Outstanding 834908 | Shares Floating 678238 | ||
Percent Insiders 29.65 | Percent Institutions 15.02 |
Upturn AI SWOT
Movano Inc

Company Overview
History and Background
Movano Inc. was founded in 2018 and is focused on developing non-invasive wearable technology to improve the accessibility and affordability of healthcare. They aim to use radio frequency (RF) technology to monitor various health parameters.
Core Business Areas
- Medical Devices: Development of wearable devices for continuous health monitoring, including heart rate, sleep, SpO2, respiratory rate and glucose trends using RF technology.
Leadership and Structure
The leadership team includes John Mastrototaro as CEO and a board of directors with expertise in medical technology and business development. The company is structured around research and development, engineering, and regulatory affairs.
Top Products and Market Share
Key Offerings
- Evie Ring: A smart ring designed for women's health monitoring, targeting the $60 billion women's health market. Competitors include Oura Ring and Fitbit.
Market Dynamics
Industry Overview
The wearable medical device market is experiencing rapid growth, driven by increasing consumer interest in personal health monitoring and advancements in sensor technology. There's a need for non-invasive accurate monitoring of various health parameters.
Positioning
Movano is positioning itself as a leader in non-invasive RF-based health monitoring technology, with a focus on women's health. Their competitive advantage lies in their proprietary RF sensor technology.
Total Addressable Market (TAM)
The total addressable market for wearable health technology is estimated to be in the hundreds of billions of dollars. Movano aims to capture a portion of this market through their Evie Ring and future products.
Upturn SWOT Analysis
Strengths
- Proprietary RF sensor technology
- Focus on women's health
- Potential for non-invasive glucose monitoring
Weaknesses
- Pre-revenue company
- Reliance on regulatory approvals
- Limited market presence compared to established players
Opportunities
- Partnerships with healthcare providers
- Expansion into new health monitoring applications
- Increasing demand for remote patient monitoring
Threats
- Competition from established wearable device companies
- Regulatory hurdles
- Technological advancements by competitors
Competitors and Market Share
Key Competitors
- FIT
- OURA
Competitive Landscape
Movano faces stiff competition from established players like Fitbit and Oura, which have significant market share and brand recognition. Movano's success depends on differentiating its technology and targeting niche markets.
Growth Trajectory and Initiatives
Historical Growth: Since its founding, Movano's growth has been focused on R&D and clinical studies. There is currently no market revenue.
Future Projections: Future growth depends on obtaining regulatory approvals and commercializing their products, particularly the Evie Ring. Analyst estimates are highly speculative.
Recent Initiatives: Recent initiatives include finalizing the design of the Evie Ring, conducting clinical trials, and engaging with regulatory agencies.
Summary
Movano is a development-stage company focused on innovative health technology. While they have promising technology in RF based health monitoring and a focus on women's health, they face significant challenges in securing regulatory approvals and competing with larger, established companies. Cash burn is a concern as they have no revenue. Future success depends on the successful launch of the Evie Ring and expansion into new applications.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- SEC filings
- Analyst reports
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Investment decisions should be based on individual research and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Movano Inc
Exchange NASDAQ | Headquaters Pleasanton, CA, United States | ||
IPO Launch date 1999-08-05 | CEO, President & Director Dr. John Mastrototaro Ph.D. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 32 | Website https://movano.com |
Full time employees 32 | Website https://movano.com |
Movano Inc., a technology company, engages in the development of a platform to deliver healthcare solutions at the intersection of medical and consumer devices. It offers Evie Ring, a wearable device for women that combines health and wellness metrics comprising resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. The company develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. It sells its products through its website, retail or other distribution channels, value-added resellers (VARs), as well as partnering with OEMs. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is headquartered in Pleasanton, California.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.